Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06701929

The Impact of Fasting Duration on Quality of Recovery After Cesarean Section

This study will evaluate the effect of fasting duration and elective c-section start time on the overall quality of recovery. Patients will be seen 24 hours after surgery to answer 11 questions on their overall recovery after surgery. Several factors will be tracked to determine their effect on recovery, with the primary variable of interesting

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

Female

Study type

Observational

Primary location

Jewish General Hospital

Montreal, Quebec, H3T1E2, Canada

Location status: Recruiting

Location contact

Mattheq Cameron, MDCM MPH FRCPC

CONTACT

[email protected]

514-340-8222 ext. 25701

About this study

This is a prospective observational study aiming to evaluate the impact of fasting time before cesarean section on the quality of recovery after c-section. All patients presenting for elective cesarean section with low transverse incision, under spinal anesthesia will be considered for inclusion.

The primary outcome will be the ObsQoR-11 score approximately 24 hours after surgery. Secondary outcomes will include the presence of nausea, vomiting or retching during surgery, the volume of intravenous fluid administered, the dose of vasopressor administered, the pain scores two hours after surgery, and the dose of opioid used in the 24 hours after surgery.

The primary analysis will be a linear regression to determine if there is a statistically significant correlation between fasting time and the ObsQoR-11 score while factoring in the variables mentioned above. Secondary analyses will determine if the fasting duration correlates with a change in any of the eleven components of the ObsQoR-11 score or the secondary outcomes listed. In addition, the fasting data will be plotted against the ObsQoR-11 score to determine if an inflection point is present.

Ten observations will be obtained for each independent variable included in the model, for a total of 100 patients in the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presenting for elective c-section under spinal anesthesia

Exclusion criteria

  • Unable to communicate in French or English
  • Urgent c-section
  • Planned general anesthesia

Treatment and study plan

Primary outcomes

  1. Obstetric Quality of Recovery (ObsQoR-11)

    Time frame: 3 months

    Obstetric quality of recovery after c-section, which has been validated based on the total score of 11 questions, with total scores ranging from 0 to 110, where 0 is the worst, and 110 is the best.

Secondary outcomes

  1. Nausea & Vomitting

    Time frame: 24 hours

    The presence of nausea vomiting or retching during or within 24 hours of surgery

  2. Numeric Rating Scale (NRS) Pain Score 2 hours after surgery

    Time frame: 2 hours after surgery

    Rating of pain, on a scale where 0 is no pain, and 10 is the worst pain imaginable.

Study contacts

Contact information is provided by the study sponsor or research team.

Matthew Cameron, MDCM MPH

CONTACT

[email protected]

514-340-8222 ext. 25701

Sponsors and collaborators

Lead sponsor

Jewish General Hospital

Other

Registry information

Official study title

How Fasting Duration Before Cesarean Section Affects the Quality of Recovery Score (ObsQoR-11)

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Nov 22, 2024
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.